로딩 중…
지수 로딩 중…
Novavax, Inc.
NVAX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$9.13-3.89%
2026-06-18
Price Chart
Novavax, Inc.+44.92%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.50B |
| Revenue | $596M |
| Net Income | $-88M |
| Total Assets | $1.04B |
| Net Assets | $461M |
| Value | |
| P/B | 3.25x |
| P/S | 2.52x |
| FCF Yield | -6.47% |
| Profitability | |
| ROE | -19.04% |
| ROA | -8.42% |
| Op. Margin | -11.19% |
| Revenue Growth | -79.07% |
| Earnings Growth | -101.83% |
| Financial Health | |
| Debt Ratio | 257.50% |
| Total Debt | $295M |
| FCF | $-97M |
| Cash | $228M |
| Current Ratio | 2.48x |
| Performance | |
| 1Y Return | 44.92% |
| 1M Return | 2.58% |
| From 52W High | -23.73% |
| 1Y MDD | -35.94% |
| Trading | |
| Volume | 7,506,997 shares |
| Trading Value | $71M |
| Per Share | |
| EPS | $2.72 |